The Role of Lifestyle and Environmental Factors in the Pathogenesis of Multiple Myeloma
- PMID: 39777794
- DOI: 10.1111/ejh.14356
The Role of Lifestyle and Environmental Factors in the Pathogenesis of Multiple Myeloma
Abstract
Objectives: The study evaluated the impact of lifestyle and environmental exposure on the etiology of multiple myeloma (MM).
Methods: A multicenter case-control study was conducted in 20 hematology centers and in 5 outpatient clinics in Poland. The questionnaire on exposure to potential risk factors including sociodemographic data, lifestyle, and environmental factors was completed.
Results: A total of 274 patients with newly diagnosed MM and 208 patients from primary healthcare centers in the control group were enrolled in the study. Regarding lifestyle, sports practiced systematically for at least half a year play a protective role in the development of myeloma (OR = 0.40, 95% CI, 0.28-0.58, p < 0.001). Among environmental factors harmful exposures that increase the likelihood of the development of MM include pesticides (OR = 3.29, p < 0.001), asphalt (OR = 2.42, p = 0.026), coal dust (OR = 2.27, p = 0.004), organic vapors (OR = 2.11, p = 0.001), metal dust (OR = 2.07, p = 0.023), exhaust fumes (OR = 2.03, p < 0.01), and chemicals (OR = 1.80, p < 0.01).
Conclusions: The pathogenesis of MM is complex with the impact of modifiable factors. Lifestyle, with physical activity, seems to play a key role.
Keywords: etiology; exposure; lifestyle; multiple myeloma; physical activity; risk factors.
© 2025 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
-
- J. Corre, N. Munshi, and H. Avet‐Loiseau, “Genetics of Multiple Myeloma: Another Heterogeneity Level?,” Blood 125 (2015): 1870–1876.
-
- A. Noone, N. Howlader, M. Krapcho, et al., SEER Cancer Statistics Review (Bethesda, MD: National Cancer Institute, 2018), 1975–2015.
-
- H. Ludwig, S. Novis Durie, A. Meckl, A. Hinke, and B. Durie, “Multiple Myeloma Incidence and Mortality Around the Globe; Interrelations Between Health Access and Quality, Economic Resources, and Patient Empowerment,” Oncologist 25 (2020): e1406–e1413.
-
- D. D. Alexander, P. J. Mink, H.‐O. Adami, et al., “Multiple Myeloma: A Review of the Epidemiologic Literature,” International Journal of Cancer 120 (2007): 40–61.
-
- A. J. Greenberg, S. V. Rajkumar, and C. M. Vachon, “Familial Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: Epidemiology, Risk Factors, and Biological Characteristics,” Blood 119 (2012): 5359–5366.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
